Martin Tolstrup

Has grant

Professor

Aarhus University

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Martin Tolstrup is a faculty member at Aarhus University in Denmark. His research focuses on virology and immunology, particularly in relation to SARS-CoV-2, HIV, and vaccine responses. Recent publications include investigations into antibody delivery systems, immune responses in various populations, and the implications of environmental toxins on vaccination efficacy.

Recent Grants

Grant: Close

A long-term study of cellular immunity

Open Date: 2021-09-01

Close Date: 2023-09-01

Grant: Close

Development of monoclonal antibodies for COVID-19

Open Date: 2020-05-01

Close Date: 2021-12-01

Grant: Close

CoroNAT: Coronavirus Neutralising antibody therapy

Open Date: 2020-04-01

Close Date: 2021-10-01

Grant: Close

Immunovirology to cure HIV

Open Date: 2019-09-01

Close Date: 2022-03-01

Grant: Close

Viral specific T cells

Open Date: 2019-09-01

Close Date: 2025-04-01

Articles (22)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (34)

Susan Mikkelsen

Aarhus University

DENMARK

Martin Tolstrup

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (22)

Factors influencing virologic control during analytical treatment interruptions in HIV cure trials - a pooled analysis of individual level data.

Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis

Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2

Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients

Single-Cell Analysis Reveals That CD47 mRNA Expression Correlates with Immune Cell Activation, Antiviral Isgs, and Cytotoxicity

TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity

Longitudinal evaluation of SARS-CoV-2 T cell immunity over 2 years following vaccination and infection

Development of single-cell transcriptomic atlas of human plasmacytoid dendritic cells from people with HIV-1

Antibody response to SARS-CoV-2 mRNA vaccination in Danish adults exposed to perfluoroalkyl substances (PFASs)

Nanobody-mediated complement activation to kill HIV-infected cells

Redirector of Vaccine-induced Effector Responses (RoVER) for specific killing of cellular targets

Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus

Omicron variant-specific serological imprinting following BA.1 or BA.4/5 bivalent vaccination and previous SARS-CoV-2 infection

A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses

Long-term humoral and cellular immunity after primary SARS-CoV-2 infection

TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study.

Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial

Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deaths.

Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound

Effect of age on innate and adaptive immunity in hospitalized covid-19 patients

Collaborators (34)

Susan Mikkelsen

Christophe PARIZOT

Rune Hartmann

Metz Christine

Esben Budtz-Jørgensen

Clíona Ní Cheallaigh

Jacob Thyrsted

Pierre Vabres

Mads Kjolby

Leif G. Hanitsch

Line Reinert

Rasmus Bak

Ida Monrad Johannsen

Nick Stub Laursen

Jörg Hamann

Thomas Benfield

Jesper Gunst

Ole Søgaard

Marianne Kragh Thomsen

Rikke Olesen

Nina Breinholt Stærke

Isik Somuncu Johansen

Lars Østergaard

Anna Karina Juhl

Martijn Beudel

Emma Connolly

Kristine Raaby Jakobsen

Martin R. Jakobsen

qiang pan-hammarstrom

Giorgio CASARI

Eleftherios Michailidis

Maria C. Puertas

Renee M. van der Sluis

Anne Troldborg

Make your next move.